Abstract
Chronic osteomyelitis, a bone infection caused by bacteria, requires extensive parenteral treatments. With an aim to develop bioactive glass with antibacterial properties to resist such infections, bioactive glasses with bismuth oxide as the dopant in various amounts up to 8 wt% were prepared. X-ray diffraction patterns and Fourier-transform infrared spectra of glass samples after immersion in simulated body fluid showed the presence of hydroxyapatite (HAp) and hydroxyl carbonate apatite for all samples except with the one having Bi2O3 substitution of 8 wt%. In vitro cell proliferation by MTT assay studies using a mouse fibroblast cell line (NIH3T3) have also been carried out. Primary antimicrobial activity of the glass particles was analyzed against Escherichia coli (E. coli) using broth microdilution method which exhibited bacteriostatic effects and bactericidal properties in selected samples. The combination of bioactivity, cell proliferation, and antibacterial properties of selected Bismuth-containing bioactive glasses could be exploited in treating bone-related infections.
Similar content being viewed by others
References
L.L. Hench and J.R. Jones: Bioactive glasses: Frontiers and challenges. Front. Bioeng. Biotechnol. 3, 1 (2015).
L.L. Hench: The story of Bioglass®. J. Mater. Sci.: Mater. Med. 17, 967 (2006).
Ö.H. Andersson, G. Liu, K.H. Karlsson, L. Niemi, J. Miettinen, and J. Juhanoja: In vivo behaviour of glasses in the SiO2–Na2O–CaO–P2O5–Al2O3–B2O3 system. J. Mater. Sci.: Mater. Med. 1, 219 (1990).
M. Brink, T. Turunen, R-P. Happonen, and A. Yli-Urpo: Compositional dependence of bioactivity of glasses in the system Na2O–K2O–MgO–CaO–B2O3–P2O5–SiO2. J. Biomed. Mater. Res., Part A 37, 114 (1997).
D.P. Lew and F.A. Waldvogel: Osteomyelitis. Lancet 364, 369 (2004).
G. Sakoulas and R.C. Moellering: Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains. Clin. Infect. Dis. 46, S360 (2008).
W-T. Jia, Q. Fu, W-H. Huang, C-Q. Zhang, and M.N. Rahaman: Comparison of borate bioactive glass and calcium sulfate as implants for the local delivery of teicoplanin in the treatment of methicillin-resistant Staphylococcus aureus-induced osteomyelitis in a rabbit model. Antimicrob. Agents Chemother. 59, 7571 (2015).
I. Allan, H. Newman, and M. Wilson: Antibacterial activity of particulate Bioglass® against supra-and subgingival bacteria. Biomaterials 22, 1683 (2001).
M. Bellantone, H.D. Williams, and L.L. Hench: Broad-spectrum bactericidal activity of Ag2O-doped bioactive glass. Antimicrob. Agents Chemother. 46, 1940 (2002).
H. Zhu, C. Hu, F. Zhang, X. Feng, J. Li, T. Liu, J. Chen, and J. Zhang: Preparation and antibacterial property of silver-containing mesoporous 58S bioactive glass. Mater. Sci. Eng., C 42, 22 (2014).
M. Ottomeyer, A. Mohammadkah, D. Day, and D. Westenberg: Broad-spectrum antibacterial characteristics of four novel borate-based bioactive glasses. Adv. Microbiol. 6, 776 (2016).
A.M. Mulligan, M. Wilson, and J.C. Knowles: Effect of increasing silver content in phosphate-based glasses on biofilms of Streptococcus sanguis. J. Biomed. Mater. Res., Part A 67, 401 (2003).
E.A.A. Neel, I. Ahmed, J. Pratten, S.N. Nazhat, and J.C. Knowles: Characterisation of antibacterial copper releasing degradable phosphate glass fibres. Biomaterials 26, 2247 (2005).
A.M. Mulligan, M. Wilson, and J.C. Knowles: The effect of increasing copper content in phosphate-based glasses on biofilms of Streptococcus sanguis. Biomaterials 24, 1797 (2003).
Y-F. Goh, A.Z. Alshemary, M. Akram, M.R.A. Kadir, and R. Hussain: In vitro characterization of antibacterial bioactive glass containing ceria. Ceram. Int. 40, 729 (2014).
D.W. Bierer: Bismuth subsalicylate: History, chemistry, and safety. Rev. Infect. Dis. 12, S3 (1990).
J.R. Lambert and P. Midolo: The actions of bismuth in the treatment of Helicobacter pylori infection. Aliment. Pharmacol. Ther. 11, 27 (1997).
M. Parirokh and M. Torabinejad: Mineral trioxide aggregate: A comprehensive literature review—Part I: Chemical, physical, and antibacterial properties. J. Endod. 36, 16 (2010).
M. Torabinejad and M. Parirokh: Mineral trioxide aggregate: A comprehensive literature review—Part II: Leakage and biocompatibility investigations. J. Endod. 36, 190 (2010).
T.J. Webster, E.A. Massa-Schlueter, J.L. Smith, and E.B. Slamovich: Osteoblast response to hydroxyapatite doped with divalent and trivalent cations. Biomaterials 25, 2111 (2004).
G. Ciobanu, A.M. Bargan, and C. Luca: New bismuth-substituted hydroxyapatite nanoparticles for bone tissue engineering. JOM 67, 2534 (2015).
S. Heid, P.R. Stoessel, T.T. Tauböck, W.J. Stark, M. Zehnder, and D. Mohn: Incorporation of particulate bioactive glasses into a dental root canal sealer. Biomed. Glasses 2, 29 (2016).
D. Mohn, M. Zehnder, T. Imfeld, and W.J. Stark: Radio-opaque nanosized bioactive glass for potential root canal application: Evaluation of radiopacity, bioactivity and alkaline capacity. Int. Endontic. J. 43, 210 (2010).
T. Kokubo, H. Kushitani, S. Sakka, T. Kitsugi, and T. Yamamuro: Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A–W3. J. Biomed. Mater. Res. 24, 721 (1990).
S.A. Bernard, V.K. Balla, N.M. Davies, S. Bose, and A. Bandyopadhyay: Bone cell–materials interactions and Ni ion release of anodized equiatomic NiTi alloy. Acta Biomater. 7, 1902 (2011).
S. Bodhak, V.K. Balla, S. Bose, A. Bandyopadhyay, U. Kashalikar, S.K. Jha, and S. Sastri: In vitro biological and tribological properties of transparent magnesium aluminate (Spinel) and aluminum oxynitride (ALON®). J. Mater. Sci.: Mater. Med. 22, 1511 (2011).
J.M. Andrews: Determination of minimum inhibitory concentrations. J. Antimicrob. Chemother. 48, 5 (2001).
X. Ou, S. Xu, J.M. Warnett, S.M. Holmes, A. Zaheer, A.A. Garforth, M.A. Williams, Y. Jiao, and X. Fan: Creating hierarchies promptly: Microwave-accelerated synthesis of ZSM-5 zeolites on macrocellular silicon carbide (SiC) foams. Chem. Eng. J. 312, 1 (2017).
K.M. El Badry, F.A. Moustaffa, M.A. Azooz, and F.H. El Batal: Infrared absorption spectroscopy of some bio-glasses before and after immersion in various solutions. Indian J. Pure Appl. Phys. 38, 741 (2000).
S. Koutsopoulos: Synthesis and characterization of hydroxyapatite crystals: A review study on the analytical methods. J. Biomed. Mater. Res. 62, 600 (2002).
F.Z. Ren and Y. Leng: Carbonated apatite, type-A or type-B? Key Eng. Mater. 493, 293 (2012).
D.M. Ibrahim, A.A. Mostafa, and S.I. Korowash: Chemical characterization of some substituted hydroxyapatites. Chem. Cent. J. 5, 74 (2011).
I. Ardelean, S. Cora, and V. Ioncu: Structural investigation of CuO–Bi2O3–B2O3 glasses by FT-IR, Raman and UV-VIS spectroscopies. J. Optoelectron. Adv. Mater. 8, 1843 (2006).
F. He, Z. He, J. Xie, and Y. Li: IR and Raman spectra properties of Bi2O3–ZnO–B2O3–BaO quaternary glass system. Am. J. Anal. Chem. 5, 1142 (2014).
J. Massera, S. Fagerlund, L. Hupa, and M. Hupa: Crystallization mechanism of the bioactive glasses, 45S5 and S53P4. J. Am. Ceram. Soc. 95, 607 (2012).
K. Fujikura, N. Karpukhina, T. Kasuga, D.S. Brauer, R.G. Hill, and R.V. Law: Influence of strontium substitution on structure and crystallisation of Bioglass® 45S5. J. Mater. Chem. 22, 7395 (2012).
X. Wang, S. Fagerlund, J. Massera, B. Södergård, and L. Hupa: Do properties of bioactive glasses exhibit mixed alkali behavior? J. Mater. Sci. 52, 8986 (2017).
K.C. da Silva Gasque, L.P. Al-Ahj, R.C. Oliveira, and A.C. Magalhães: Cell density and solvent are critical parameters affecting formazan evaluation in MTT assay. Braz. Arch. Biol. Technol. 57, 381 (2014).
C.R. Kruse, M. Singh, S. Targosinski, I. Sinha, J.A. Sørensen, E. Eriksson, and K. Nuutila: The effect of pH on cell viability, cell migration, cell proliferation, wound closure, and wound reepithelialization: In vitro and in vivo study. Wound Repair Regen. 25, 260 (2017).
A-M. Galow, A. Rebl, D. Koczan, S.M. Bonk, W. Baumann, and J. Gimsa: Increased osteoblast viability at alkaline pH in vitro provides a new perspective on bone regeneration. Biochem. Biophys. Rep. 10, 17 (2017).
F. Thomas, B. Bialek, and R. Hensel: Medical use of bismuth: The two sides of the coin. J. Clin. Toxicol. S3, 495 (2011).
P.T. Reynolds, K.C. Abalos, J. Hopp, and M.E. Williams: Bismuth toxicity: A rare cause of neurologic dysfunction. Int. J. Clin. Med. 3, 46 (2012).
Q.L. Feng, J. Wu, G.Q. Chen, F.Z. Cui, T.N. Kim, J.O. Kim, T.N. Kim, and J.O. Kim: A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J. Biomed. Mater. Res. 52, 662 (2000).
ACKNOWLEDGMENTS
Authors would like to express their grateful thanks to Dr. K. Muraleedharan, Director, CSIR-CGCRI and Dr. Ranjan Sen, Head, Glass division for their encouragement and support toward this work. The financial help from P 81-113 of the CSIR Extramural Research Fund for Young Scientists and CSIR-HRDG (Extramural Research Group) for providing GATE-JRF fellowship to SPS for pursuing Integrated M.Tech Ph.D. program is gratefully acknowledged. The authors gratefully acknowledge the suggestions and experimental help offered by Dr. Biswanath Kundu, Senior Scientist and Dr. Vamsi K. Balla, Senior Principal Scientist, Bioceramics and Coating Division, CSIR-CGCRI.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Prasad S, S., Ratha, I., Adarsh, T. et al. In vitro bioactivity and antibacterial properties of bismuth oxide modified bioactive glasses. Journal of Materials Research 33, 178–190 (2018). https://doi.org/10.1557/jmr.2017.442
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1557/jmr.2017.442